FDA approves quick-action insulin twin, a first for diabetes care
interestingengineering.com/health/insul...
interestingengineering.com/health/insul...
FDA approves quick-action insulin twin, a first for diabetes care
The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood sugar spikes.
interestingengineering.com
February 20, 2025 at 2:05 AM
FDA approves quick-action insulin twin, a first for diabetes care
interestingengineering.com/health/insul...
interestingengineering.com/health/insul...
FDA Approves Merilog: A Landmark Biosimilar Insulin for Diabetes Management#United_States#FDA#Silver_Spring#diabetes#Merilog
FDA Approves Merilog: A Landmark Biosimilar Insulin for Diabetes Management
The FDA has approved Merilog, the first rapid-acting insulin biosimilar, aimed at enhancing diabetes care for patients across the U.S.
third-news.com
February 14, 2025 at 8:29 PM
FDA Approves Merilog: A Landmark Biosimilar Insulin for Diabetes Management#United_States#FDA#Silver_Spring#diabetes#Merilog
The FDA has approved Merilog, the first rapid-acting insulin biosimilar to NovoLog, enhancing diabetes treatment options and affordability.
jcst2d.com/index.php?vi...
#FDAApproval #Merilog #InsulinBiosimilar #DiabetesCare #NovoLog
jcst2d.com/index.php?vi...
#FDAApproval #Merilog #InsulinBiosimilar #DiabetesCare #NovoLog
February 22, 2025 at 6:01 PM
The FDA has approved Merilog, the first rapid-acting insulin biosimilar to NovoLog, enhancing diabetes treatment options and affordability.
jcst2d.com/index.php?vi...
#FDAApproval #Merilog #InsulinBiosimilar #DiabetesCare #NovoLog
jcst2d.com/index.php?vi...
#FDAApproval #Merilog #InsulinBiosimilar #DiabetesCare #NovoLog
FDA Approves First Rapid-Acting Insulin Biosimilar Product (insulin aspart branded as Merilog from Sanofi-Aventis U.S. LLC) for Treatment of Diabetes @fda.gov www.fda.gov/news-events/...
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
FDA approved the first rapid-acting biosimilar insulin product, Merilog (insulin-aspart-szij), to improve glycemic control in adults and children with diabetes
www.fda.gov
February 15, 2025 at 10:09 PM
FDA Approves First Rapid-Acting Insulin Biosimilar Product (insulin aspart branded as Merilog from Sanofi-Aventis U.S. LLC) for Treatment of Diabetes @fda.gov www.fda.gov/news-events/...
Yes, the FDA has approved Biocon Biologics insulin aspart biosimilar to be branded as Kirsty (and sold under other drug companies' brand names). Recall that on Valentine's Day, FDA approved Sanofi's copy of insulin aspart branded as Merilog.
July 21, 2025 at 1:10 PM
Yes, the FDA has approved Biocon Biologics insulin aspart biosimilar to be branded as Kirsty (and sold under other drug companies' brand names). Recall that on Valentine's Day, FDA approved Sanofi's copy of insulin aspart branded as Merilog.
FDA Approves First Fast-Acting Insulin Biosimilar for Diabetes - JAMA Network - goo.gl/alerts/pDce1W #GoogleAlerts
FDA Approves First Fast-Acting Insulin Biosimilar for Diabetes
The US Food and Drug Administration (FDA) recently approved the rapid-acting human insulin analog insulin-aspart-szjj, marketed as Merilog, as a biosimilar to insulin aspart (Novolog).
goo.gl
March 16, 2025 at 9:22 PM
FDA Approves First Fast-Acting Insulin Biosimilar for Diabetes - JAMA Network - goo.gl/alerts/pDce1W #GoogleAlerts
As biosimilars of insulin aspart proliferate (FDA has approved two in 2025: Sanofi's Merilog and Biocon's Kirsty), Novo Nordisk trials a highly-concentrated Novel U-500 Insulin Aspart Formulation diabetesjournals.org/care/article...
Pharmacokinetics and Pharmacodynamics of a Novel U500 Insulin Aspart Formulation: A Randomized, Double-Blind, Crossover Study in People With Type 1 Diabetes
OBJECTIVE. To evaluate the pharmacokinetics, pharmacodynamics, and safety of a novel U500 insulin aspart formulation (AT278 U500) compared with insulin asp
diabetesjournals.org
September 11, 2025 at 6:11 PM
As biosimilars of insulin aspart proliferate (FDA has approved two in 2025: Sanofi's Merilog and Biocon's Kirsty), Novo Nordisk trials a highly-concentrated Novel U-500 Insulin Aspart Formulation diabetesjournals.org/care/article...
With this approval, the U.S. now has 3 biosimilars of insulin aspart: Sanofi's Merilog, Biocon Biologics Kirsty and now Meitheal Pharmaceutials Garzulys.
August 3, 2026 at 6:49 PM
With this approval, the U.S. now has 3 biosimilars of insulin aspart: Sanofi's Merilog, Biocon Biologics Kirsty and now Meitheal Pharmaceutials Garzulys.
Defense Minister Katz, visiting the Merilog memorial, stated that while Israel maintains a friendship with the U.S., they have never asked for American involvement in Syria, Lebanon, or Gaza, emphasizing that Israel relies solely on its own people and the IDF.
July 19, 2026 at 3:09 PM
Defense Minister Katz, visiting the Merilog memorial, stated that while Israel maintains a friendship with the U.S., they have never asked for American involvement in Syria, Lebanon, or Gaza, emphasizing that Israel relies solely on its own people and the IDF.
This becomes the second copy of Novolog to hit the U.S. market (the first was Sanofi’s copy branded as Merilog which received FDA approval on Valentine’s Day).
July 20, 2025 at 9:08 PM
This becomes the second copy of Novolog to hit the U.S. market (the first was Sanofi’s copy branded as Merilog which received FDA approval on Valentine’s Day).
Sanofi is the only company which sells all prandial insulin analogue varieties: its own glulisine (Apidra), lispro (Admelog), and aspart (Merilog). And, it has mfg coupons at www.teamingupfordiabetes.com/sanofidiabet...
Saving Card for Sanofi Diabetes Medication | TeamingUp
Sign up for Sanofi diabetes medication savings card. Eligible patients can receive savings on their prescriptions.
www.teamingupfordiabetes.com
March 3, 2025 at 7:03 PM
Sanofi is the only company which sells all prandial insulin analogue varieties: its own glulisine (Apidra), lispro (Admelog), and aspart (Merilog). And, it has mfg coupons at www.teamingupfordiabetes.com/sanofidiabet...
Of note is that biosimilar (and follow-on biologic, a different FDA regulatory pathway) insulins are poised to hit the U.S. market in 2025. On Feb. 14, 2025, the U.S. FDA approved a biosimilar of Novolog branded as Merilog from Sanofi Aventis. www.fda.gov/news-events/...
March 3, 2025 at 6:54 PM
Of note is that biosimilar (and follow-on biologic, a different FDA regulatory pathway) insulins are poised to hit the U.S. market in 2025. On Feb. 14, 2025, the U.S. FDA approved a biosimilar of Novolog branded as Merilog from Sanofi Aventis. www.fda.gov/news-events/...
FDA OKs First Rapid-Acting Insulin "Biosimilar" for Diabetes @medpagetoday.bsky.social www.medpagetoday.com/endocrinolog...
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
Approval makes Merilog the third insulin biosimilar
www.medpagetoday.com
February 23, 2025 at 2:42 PM
FDA OKs First Rapid-Acting Insulin "Biosimilar" for Diabetes @medpagetoday.bsky.social www.medpagetoday.com/endocrinolog...
Catch my blog coverage "FDA Approves Merilog (insulin-aspart-szjj) as First Prandial Insulin Biosimilar Product for Treatment of Diabetes blog.sstrumello.com/2025/02/fda-...
FDA Approves Merilog (insulin-aspart-szjj) as First Prandial Insulin Biosimilar Product for Treatment of Diabetes
My followers might recall my groundbreaking January 8, 2007 article (see that at https://blog.sstrumello.com/2007/01/business-of-diabetes-re...
blog.sstrumello.com
February 19, 2025 at 2:02 AM
Catch my blog coverage "FDA Approves Merilog (insulin-aspart-szjj) as First Prandial Insulin Biosimilar Product for Treatment of Diabetes blog.sstrumello.com/2025/02/fda-...
FYI, the image of the box which contains the Merilog biosimilar is here
February 18, 2025 at 10:13 PM
FYI, the image of the box which contains the Merilog biosimilar is here
The U.S. Food and Drug Administration (FDA) has approved Merilog, the first rapid-acting insulin biosimilar to Novolog (insulin aspart), providing a new option for diabetes management.
#DiabetesCare #FDAApproval #Merilog #InsulinBiosimilar #HealthTech #MedicalInnovation
#DiabetesCare #FDAApproval #Merilog #InsulinBiosimilar #HealthTech #MedicalInnovation
February 21, 2025 at 4:34 PM
The U.S. Food and Drug Administration (FDA) has approved Merilog, the first rapid-acting insulin biosimilar to Novolog (insulin aspart), providing a new option for diabetes management.
#DiabetesCare #FDAApproval #Merilog #InsulinBiosimilar #HealthTech #MedicalInnovation
#DiabetesCare #FDAApproval #Merilog #InsulinBiosimilar #HealthTech #MedicalInnovation
this 2025 skeet brought to you by :
Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) Lyophilized Powder for Injection
Vimkunya (chikungunya vaccine, recombinant) Injection
Merilog (insulin aspart-szjj) Injection
Ospomyv (denosumab-dssb) Injection
Xbryk (denosumab-dssb) Injection
Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) Lyophilized Powder for Injection
Vimkunya (chikungunya vaccine, recombinant) Injection
Merilog (insulin aspart-szjj) Injection
Ospomyv (denosumab-dssb) Injection
Xbryk (denosumab-dssb) Injection
February 22, 2025 at 1:40 PM
this 2025 skeet brought to you by :
Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) Lyophilized Powder for Injection
Vimkunya (chikungunya vaccine, recombinant) Injection
Merilog (insulin aspart-szjj) Injection
Ospomyv (denosumab-dssb) Injection
Xbryk (denosumab-dssb) Injection
Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) Lyophilized Powder for Injection
Vimkunya (chikungunya vaccine, recombinant) Injection
Merilog (insulin aspart-szjj) Injection
Ospomyv (denosumab-dssb) Injection
Xbryk (denosumab-dssb) Injection
News for diabetes care! The #FDA has approved #Merilog, the 1st rapid-acting insulin biosimilar & 3rd biosimilar insulin product approved in the U.S. 💉
Biosimilars like Merilog can help make insulin more accessible & affordable for the millions who rely on it.
Read more: www.fda.gov/news-events/...
Biosimilars like Merilog can help make insulin more accessible & affordable for the millions who rely on it.
Read more: www.fda.gov/news-events/...
February 27, 2025 at 2:32 PM
News for diabetes care! The #FDA has approved #Merilog, the 1st rapid-acting insulin biosimilar & 3rd biosimilar insulin product approved in the U.S. 💉
Biosimilars like Merilog can help make insulin more accessible & affordable for the millions who rely on it.
Read more: www.fda.gov/news-events/...
Biosimilars like Merilog can help make insulin more accessible & affordable for the millions who rely on it.
Read more: www.fda.gov/news-events/...
Advance Release In Brief: Merilog - A NovoLog Biosimilar bit.ly/4idSv4q
March 11, 2025 at 3:30 PM
Advance Release In Brief: Merilog - A NovoLog Biosimilar bit.ly/4idSv4q
The FDA recently approved a new drug, called Merilog, which can aid in regulating blood sugar levels in those with diabetes! Look it up! #UISPsyofEating
February 17, 2025 at 8:41 PM
The FDA recently approved a new drug, called Merilog, which can aid in regulating blood sugar levels in those with diabetes! Look it up! #UISPsyofEating
FDA Approves First NovoLog® (insulin aspart) Biosimilar: Sanofi’s Merilog™ / Merilog SoloStar®
FDA Approves First NovoLog® (insulin aspart) Biosimilar: Sanofi’s Merilog™ / Merilog SoloStar®
On February 14, 2025, the FDA approved Sanofi’s Merilog™ / Merilog SoloStar® (insulin aspart-szjj), the first biosimilar of Novo Nordisk’s...
www.jdsupra.com
February 24, 2025 at 3:49 PM
FDA Approves First NovoLog® (insulin aspart) Biosimilar: Sanofi’s Merilog™ / Merilog SoloStar®
FDA Approves First Rapid-Acting Insulin Biosimilar Product for the Treatment of Diabetes
FDA Approves First Rapid-Acting Insulin Biosimilar Product for the Treatment of Diabetes
On February 14, 2025, the U.S. Food and Drug Administration (“FDA”) approved Sanofi-Aventis U.S. LLC’s (“Sanofi”) MERILOG™ (insulin-aspart-szjj),...
www.jdsupra.com
February 20, 2025 at 9:05 PM
FDA Approves First Rapid-Acting Insulin Biosimilar Product for the Treatment of Diabetes
